Evogene Ltd.

Report Publication Announcement • Jul 31, 2019

Evogene Reports Second Quarter 2019 Financial Results; Investors Slides false

����� ��"�	2 380
EVOGENE LTD
Corporation no: 512838723	11441
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	31/07/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-079339	Time of broadcast: 10:58 10:52:32

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onEvogene Reports Second Quarter 2019 Financial Results; Investors Slides

Evogene_Q2_results_and_Slides_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 25/06/2019
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Bartov Pinto Amitai Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612002 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: amitai.bartov@evogene.com 1